Now playing Next Economy Denmark's GDP soars thanks to growing pharma sector Denmark's gross domestic product (GDP) grew 2% in the fourth quarter of 2023, largely bolstered by the country's expanding pharmaceutical sector. 20/02/2024
Now playing Next Markets Novo Nordisk crossroads: Can the pharma giant address the supply woes? Novo Nordisk faces a pivotal moment as it grapples with supply issues amid soaring demand for its weight-loss drugs. Despite impressive financial gains and market dominance, the Danish pharma giant must navigate a critical decision. 10/02/2024
Now playing Next The Big Question Novartis doctor on Big Pharma’s battle against climate change If the healthcare industry was a country, it would be the fifth largest polluter on Earth. 01/02/2024
Now playing Next Business Drugmaker Novo Nordisk reaches market value of $500 million Demand for obesity drugs has pushed Novo Nordisk's share price to new highs. 31/01/2024
Now playing Next Green News EU Policy. Pharma and cosmetics industries to pay for wastewater treatment ‘Polluter pays’ principle mandates key industries to take responsibility for spreading micropollutants. 30/01/2024
Now playing Next Health news €2.5 million drug now approved in Ireland, Belgium and the Netherlands Libmeldy - a treatment for a rare disease costing €2.5 million - has become available in Ireland, Belgium and the Netherlands. 26/01/2024
Now playing Next Health news 'I’m scared': UK patients struggle to access epilepsy medication A national shortage of some epilepsy medications in the UK is putting patients' safety at risk. 23/01/2024
Now playing Next Health news Scientists discover first new antibiotics in over 60 years using AI A new class of antibiotics for drug-resistant Staphylococcus aureus (MRSA) bacteria which was discovered using more transparent deep learning models. 31/12/2023
Now playing Next Health news AI could change the game for drug development Biotech startups are using AI to speed drug discovery, revolutionising pharmaceuticals. Iktos aims to halve pre-clinical drug discovery time. 07/12/2023
Now playing Next Health news Americans turn to alternatives amid Ozempic shortage Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug. 04/12/2023
Now playing Next Health news Australia has apologised to thalidomide survivors. What about Europe? The Australian government issued formal apologies to victims of thalidomide this week. In Europe, the recognition of victims has been heterogeneous. 01/12/2023
Now playing Next Business Denmark's Novo Nordisk invests €2.1 billion in France Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug. 24/11/2023
Now playing Next France Five hundred new jobs coming in Chartres, south of Paris On Thursday, Danish pharmaceutical giant Novo Nordisk announced a major investment in a French production site to expand the capacity and manufacturing of a blockbuster anti-obesity drug. 24/11/2023
Now playing Next Healthcare France debates amendment on biomedicine substitution in pharmacies An amendment is being debated on whether pharmacies can substitute approved replacements for biological medicines, but patient organisations have raised concerns. 15/11/2023
Now playing Next Business AstraZeneca announces new anti-obesity drug deal and positive profit AstraZeneca's share price climbed on Thursday after it announced a multi-billion dollar deal with Chinese biopharmaceutical company Eccogene to produce a new anti-diabetes and obesity drug. 10/11/2023
Now playing Next Health news Growing drugs shortage is leaving pharmacists and patients in the dark Shortages of common older medicines are increasing. Experts say it’s in part because pharmaceutical companies are de-incentivised from producing them. 10/10/2023
Now playing Next Business Denmark's Novo Nordisk and South Africa's Aspen to produce insulin for African patients Last year, the World Health Organization estimated that there are 24 million adults living with diabetes in Africa, saying the number is expected to rise to 55 million by 2045. 20/09/2023
Now playing Next Economy Denmark's economy boosted by anti-obesity treatments Over the first six months of the year, Danish GDP rose by 1.7% year-on-year, according to national statistics, but without the contribution of the pharmaceutical industry, it would have fallen by 0.3%. 06/09/2023
Now playing Next Health news Anti-obesity drug market booming with new class of popular drugs Designed to treat obesity, a new class of drugs is also an opportunity for investors. 24/08/2023
Now playing Next Health news Weight-loss drug Wegovy could reduce risk of heart attack or stroke Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient. 09/08/2023